vesicare 5 mg
orifarm as - solifenacinsuksinat - tablett, filmdrasjert - 5 mg
vesicare 10 mg
orifarm as - solifenacinsuksinat - tablett, filmdrasjert - 10 mg
vesicare 10 mg
orifarm as - solifenacinsuksinat - tablett, filmdrasjert - 10 mg
nimotop 0.2 mg/ ml
orifarm as - nimodipin - infusjonsvæske, oppløsning - 0.2 mg/ ml
nimotop 0.2 mg/ ml
orifarm as - nimodipin - infusjonsvæske, oppløsning - 0.2 mg/ ml
ontilyv
bial portela & companhia s.a. - opicapone - parkinsonsykdom - anti-parkinson medisiner - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiske midler - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
mezavant 1200 mg
orifarm as - mesalazin - enterodepottablett - 1200 mg
mezavant 1200 mg
orifarm as - mesalazin - enterodepottablett - 1200 mg
mezavant 1200 mg
orifarm as - mesalazin - enterodepottablett - 1200 mg